About
Assaf Barnea is founding managing partner of Sanara Capital and CEO of Sanara Ventures, a healthcare innovation fund backed by Philips and Teva that invests in digital health, medical devices, and bio-convergence technologies since 2014. He previously served as CEO of Kinrot Ventures, which was acquired by Hutchison Water in 2012, and advised the World Bank's IFC venture capital team, where he co-founded the Tech Emerge program. Barnea holds an LLB and business degree from the Interdisciplinary Center in Herzelia and a BA in political science and psychology from Tel-Aviv University.
Experience
- Sanara VenturesCEOcurrent2014 β presentIsrael
- 8400 - The Health NetworkMember of 8400 - the health networkcurrent2017 β present
- NanoDropsChairmancurrent2020 β present
- Lydus MedicalChairmancurrent2017 β present
- TailorMedBoard Membercurrent2017 β presentTel Aviv District, Israel
- Israel Export Institute - ΧΧΧΧ ΧΧΧ¦ΧΧChairman, Life Science Advisory Boardcurrent2016 β presentTel Aviv District, Israel
- MyHomeDocChairperson2016 β 2024
- World Bank/IFC venture capital teamBusiness Consultant2014 β 2019Israel
- Kinrot VenturesCEO2007 β 2013
- CardiosenseCo Founder & Board Member2001 β 2011
- MekorotAdviser to CEO, Manager of WaTech2004 β 2007
- ComverseDirector, Busines Development2000 β 2004
Education
- Reichman UniversityLaw & Busniess1994 β 1998
- Tel Aviv UniversityPolitical Science & Phsycology1991 β 1994
- Seton Hall University1990 β 1991
Skills & more
+12 more
Strategic PartnershipsCorporate DevelopmentBusiness PlanningManagement ConsultingCleantechCompetitive AnalysisMergersR&DInvestmentsProduct DevelopmentGlobal Business DevelopmentVenture FinancingFrom Assaf's professional profile.
Same school
Also attended Reichman University153
+ 147 more
Also attended Tel Aviv University335
+ 329 more
Shared employers
Also worked at 8400 - The Health Network8
+ 2 more
Also worked at TailorMed3
Also worked at Israel Export Institute - ΧΧΧΧ ΧΧΧ¦ΧΧ2
Also worked at Comverse1
Deals Β· 15
UkkoSolo GP
via Sanara Capital Β· filed Jul 2017
ActiveAgingSolo GP
via Sanara Capital
CVAidSolo GP
via Sanara Capital
Lydus MedicalSolo GP
via Sanara Capital
NanoDropsSolo GP
via Sanara Capital
NovaSightSolo GP
via Sanara Capital
PanaceaSolo GP
via Sanara Capital
ProfilitySolo GP
via Sanara Capital
TailormedSolo GP
via Sanara Capital
VflowSolo GP
via Sanara Capital
Xtrac MedicalSolo GP
via Sanara Capital
DiscureSolo GP
via Sanara Capital
Luseed VascularSolo GP
via Sanara Capital
QLogSolo GP
via Sanara Capital
SkyHoopSolo GP
via Sanara Capital
Attribution from SEC filings, press coverage, and firm rosters. Some rows are inferred. Not right? Tell us.


























